Best Medicare Plans for High Blood Pressure Medications (2026 Guide)

Nearly 58% of Medicare beneficiaries have hypertension — and most of them are taking medications that have been generic for decades. The good news: lisinopril, losartan, amlodipine, and hydrochlorothiazide cost almost nothing on any Medicare plan. The catch: if you're on brand-name ARBs, newer combination pills, or a plan with a high drug deductible, your out-of-pocket costs can be much higher than they should be.

Why Medicare Coverage for Blood Pressure Medications Varies

Hypertension medications span the full spectrum of the Medicare formulary — from decades-old generics that cost pennies to manufacture, to brand-name combination pills that can run $150–$300/month before insurance. The same underlying molecule can be dramatically cheaper as a generic than under its brand name, and the formulary tier difference between a brand and its generic equivalent can be $100+ per month.

Every Medicare Advantage and Part D plan sets its own formulary — a tiered list of covered drugs where each tier has a different cost-sharing level. There is no universal Medicare formulary. Two plans in the same zip code can cover the same medication at Tier 1 ($0–$5) or Tier 3 ($40–$100+).

For blood pressure medications specifically, variation is driven by three factors:

• Generic vs. brand-name status. Most first-line hypertension drugs have excellent generics. If your plan places the generic on Tier 1 but the brand on Tier 3 or 4, the tier placement alone could cost you $1,000+ per year unnecessarily.
• Plan drug deductible. In 2026, some Part D plans have a drug deductible of up to $590 before benefits kick in. If your hypertension medications aren't excluded from the deductible, you could pay full retail price on them for the first few months of each year.
• Combination pills and newer formulations. Fixed-dose combination pills (like a single tablet containing two blood pressure drugs) are sometimes placed on higher tiers than their individual generic components. Patients who use combinations for convenience may pay more than those who take two separate generics.

Drug Classes and Formulary Tier Differences

There are five main classes of medications used to treat hypertension. Here's how each class behaves across Medicare formularies and what to watch for.

ACE Inhibitors

ACE inhibitors — lisinopril, enalapril, ramipril, benazepril — are almost universally generic and priced at Tier 1 across Medicare plans. Lisinopril is among the most-prescribed drugs in Medicare, and plans compete to keep it at $0 copay to attract enrollees. If you're only on an ACE inhibitor, your formulary comparison is simple: nearly every plan covers it cheaply.

The one exception: a small number of patients on ramipril (Altace brand) or perindopril (Aceon) — if the brand is specifically prescribed rather than the generic, tier placement may be higher. Always confirm with your prescriber that generic substitution is acceptable.

ARBs (Angiotensin Receptor Blockers)

Most ARBs are now available as generics: losartan, valsartan, irbesartan, and candesartan all have generic equivalents at Tier 1–2. However, olmesartan (brand: Benicar) has higher-cost brand versions, and newer combination ARBs (Azor = amlodipine/olmesartan, Tribenzor = amlodipine/olmesartan/HCTZ) are still brand-name with no generic equivalents, landing at Tier 3–4 on most plans.

If you're on a combination ARB pill for convenience, ask your cardiologist or internist whether switching to two separate generic components (e.g., generic losartan + generic amlodipine) would work clinically. In most cases it would — and the cost difference can be $100–$200/month.

Calcium Channel Blockers

Amlodipine (generic for Norvasc) is another Tier 1 staple on virtually every Medicare plan. It's among the most prescribed cardiovascular drugs in the U.S. and has been generic for decades. Other CCBs — diltiazem, verapamil, felodipine — are similarly well-covered generics. The brand-name versions (Norvasc, Cardizem) cost more if specifically requested, but there's rarely a clinical reason not to use the generic.

Diuretics (Thiazides)

Hydrochlorothiazide (HCTZ) and chlorthalidone are two of the cheapest drugs in all of Medicare — both generic, both at Tier 1 with $0–$3 copays on virtually every plan. Diuretics are almost never a source of meaningful formulary variation. If cost is a concern, your prescriber can confirm whether a thiazide diuretic is appropriate as monotherapy or adjunct to another class.

Beta-Blockers

Metoprolol succinate (extended-release), metoprolol tartrate, atenolol, carvedilol, and bisoprolol are all well-established generics. Plans typically place them at Tier 1 or Tier 2. Carvedilol CR (brand: Coreg CR) is the most notable exception — the extended-release brand formulation lands at Tier 3–4, while generic carvedilol immediate-release is Tier 1. If you're prescribed Coreg CR specifically, confirm whether generic carvedilol IR is an acceptable substitute for your condition — it often is, at a fraction of the cost.

Tier placements and copays vary by plan and change annually. Always verify your specific plan's formulary before enrolling.

Medicare Part B Coverage for Blood Pressure Monitoring

Blood pressure monitoring devices — home BP cuffs and ambulatory blood pressure monitoring (ABPM) equipment — fall under Medicare Part B as durable medical equipment (DME), but coverage is more limited than patients often expect.

Home blood pressure monitors are not automatically covered by Medicare Part B simply because you have hypertension. Coverage requires that your doctor specifically order the device and that there is a documented clinical reason. Even when ordered, reimbursement depends on whether Medicare has determined the device is medically necessary for your specific situation, and your DME supplier must be enrolled in Medicare.

Ambulatory blood pressure monitoring (ABPM) — the 24-hour portable monitor used to diagnose white coat hypertension or assess treatment effectiveness — is covered by Medicare Part B for the diagnosis of suspected white coat hypertension when certain clinical criteria are met. Your doctor submits a formal order and the claim is filed under Part B. Your standard Part B cost-sharing applies (20% after the deductible in Original Medicare).

Preventive Services and Lifestyle Program Coverage

Medicare covers several preventive services and programs that are directly relevant for people managing hypertension. Understanding these benefits can reduce your out-of-pocket spending on care that goes beyond just medications.

Cardiovascular Disease Risk Reduction Visits

Original Medicare (Part B) covers up to two intensive behavioral therapy visits per year for cardiovascular disease prevention. These visits focus on risk factor counseling — including blood pressure management, smoking cessation, diet, and physical activity. There is no cost-sharing for these visits when provided in a primary care setting (no deductible or copay applies if you have Original Medicare). Medicare Advantage plans must cover these visits with no cost-sharing.

Nutritional Counseling

Medicare Part B covers medical nutrition therapy for beneficiaries with certain conditions, including diabetes and kidney disease. For hypertension specifically, nutritional counseling is covered only if your doctor determines it is medically necessary for a covered condition (like diabetes or chronic kidney disease that often accompanies hypertension). Standalone nutritional counseling for blood pressure management without a qualifying secondary condition is not automatically covered. Check with your plan directly.

Cardiac Rehabilitation

If hypertension has progressed to a cardiac event — heart attack, coronary artery bypass, heart failure diagnosis — Medicare Part B covers cardiac rehabilitation programs (up to 36 sessions, 72 for intensive programs). The cost-sharing under Original Medicare is 20% after the Part B deductible. Medicare Advantage plans vary in their per-session copays and the facilities they cover. If you qualify for cardiac rehab, verify your plan's in-network rehab facilities and specific cost-sharing before beginning a program.

Annual Wellness Visit

Medicare covers one Annual Wellness Visit (AWV) per year at no cost to you — no deductible, no copay. The AWV includes a blood pressure check and allows your provider to update your medication list, identify cardiovascular risk factors, and refer you to preventive services. This is distinct from a standard office visit; make sure your provider bills it correctly as a wellness visit (CPT G0439) rather than an evaluation and management visit, which carries standard cost-sharing.

When Plan Choice Matters Most for Hypertension Patients

For most people managing hypertension with standard generic medications, the formulary is almost never the primary driver of plan choice — the drugs are simply too cheap across the board. Where plan selection matters more for hypertension patients:

You're on a combination pill or brand-name ARB

If you take Azor, Tribenzor, Benicar, or another brand-name combination pill, formulary differences are meaningful and worth a careful comparison. These drugs can cost $60–$200/month on higher tiers versus $10–$20 if you can switch to two separate generics.

Your plan has a drug deductible that applies to hypertension meds

In 2026, Part D deductibles can be up to $590. Most plans exempt Tier 1 generics from the deductible — but not all do. A plan that applies the full deductible to your hypertension medications means paying full retail price for them January through March (or until the deductible is met). Always check whether your specific drugs are deductible-exempt or not.

You have other conditions alongside hypertension

Hypertension rarely exists in isolation. It co-occurs with diabetes in roughly 70% of cases and with heart disease in over half. If you also take medications for those conditions — and especially if you're on expensive drugs like GLP-1 agonists, anticoagulants, or statins — the formulary comparison for your full medication list may matter much more than the hypertension drugs alone. Use your complete drug list, not just blood pressure meds, when comparing plans.

5-Step Framework for Comparing Medicare Plans for Hypertension

Choosing a plan based on premium is still the most common mistake — even when your drug costs are low, medical cost-sharing and network coverage can vary significantly. Here's the right framework:

Step 1: List every medication — not just blood pressure drugs

Be precise. Include dosage and frequency. Most hypertension patients are on multiple medications across conditions. The formulary comparison is only useful if it covers your complete list — not just the medications you associate with one condition.

Step 2: Check the drug deductible and whether your medications are exempt

Look specifically at whether your plan's drug deductible applies to your tier-level drugs. Tier 1 generics are often deductible-exempt, but confirm this in the plan's Evidence of Coverage document. A $0-premium plan with a full $590 deductible applied to all tiers can cost you more in Q1 than a plan with a modest premium and no deductible.

Step 3: Verify your primary care doctor and cardiologist (if applicable) are in-network

Hypertension management typically involves regular primary care visits and periodic lab work. For Medicare Advantage HMO plans, your doctor must be in-network or you'll face full out-of-network costs. Even for PPO plans, out-of-network cost-sharing can be substantial. Verify your specific providers are listed as in-network — don't rely solely on the carrier's provider directory, which may be out of date. Call the plan directly.

Step 4: Estimate total annual cost, not just drug costs

Hypertension management involves regular office visits, annual labs (metabolic panel, kidney function), and sometimes additional specialist consultations. Calculate your estimated total annual cost — including drug copays, office visit copays, and lab cost-sharing — not just the drug costs in isolation. A plan with slightly higher drug copays but $0 primary care visits may still be cheaper for you overall.

Step 5: Check the annual out-of-pocket maximum (MOOP)

For most hypertension-only patients, the MOOP isn't typically reached — drug and office visit costs stay manageable. But if hypertension has led to complications (kidney disease, heart failure, stroke recovery), you may face enough medical spending that the MOOP matters. In 2026, CMS caps Medicare Advantage in-network MOOP at $9,350 — but many plans set it lower. Compare MOOPs when your overall medical utilization is significant.